M. Kenyon

G. Mufti, D. Mclornan, H. de Lavallade, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Sexual function of adult long-term survivors and their partners after allogeneic hematopoietic cell transplantation in Europe (S-FAST): a study from the Transplant Complications Working Party and Nurses Group of the EBMT

D. Greenfield, J. Mooyaart, Z. Perić, 2022, Bone Marrow Transplantation.

The European Blood and Marrow Transplantation Textbook for Nurses

A. Babić, M. Kenyon, 2018, Springer International Publishing.

Use of Less-than-Lifetime (LTL) Durational Limits for Nitrosamines: Case Study of N-Nitrosodiethylamine (NDEA).

K. Cross, G. Johnson, A. Czich, 2021, Regulatory toxicology and pharmacology : RTP.

Determination of compound-specific acceptable daily intakes for 11 mutagenic carcinogens used in pharmaceutical synthesis.

Krista Dobo, Krista L Dobo, Michelle Kenyon, 2013, Regulatory toxicology and pharmacology : RTP.

Outcome of donor lymphocyte infusion after T cell-depleted allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndromes.

G. Mufti, R. Ireland, H. de Lavallade, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of pretransplant comorbidities on alemtuzumab-based reduced-intensity conditioning allogeneic hematopoietic SCT for patients with high-risk myelodysplastic syndrome and AML

G. Mufti, R. Brand, Z. Lim, 2010, Bone Marrow Transplantation.

The in vivo Pig-a assay: A report of the International Workshop On Genotoxicity Testing (IWGT) Workgroup.

K. Witt, P. White, S. Dertinger, 2015, Mutation research. Genetic toxicology and environmental mutagenesis.

Genetic toxicology in silico protocol.

Raymond R Tice, Naomi L Kruhlak, Lidiya Stavitskaya, 2019, Regulatory toxicology and pharmacology : RTP.

Outcomes of alemtuzumab‐based reduced intensity conditioning stem cell transplantation using unrelated donors for myelodysplastic syndromes

G. Mufti, B. Czepulkowski, Z. Lim, 2006, British journal of haematology.

Graft-Versus-Host Disease (GvHD) -- The European Blood and Marrow Transplantation Textbook for Nurses: Under the Auspices of EBMT

A. Babić, M. Kenyon, 2018 .

Principles of Conditioning Therapy and Cell Infusion

M. Kenyon, Sara Zulu, 2018 .

Alemtuzumab based reduced intensity conditioning allogeneic haematopoietic stem cell transplantation for myelofibrosis.

G. Mufti, N. Lea, Z. Lim, 2011, Leukemia research.

Full donor chimerism without graft-versus-host disease: the key factor for maximum benefit of pre-emptive donor lymphocyte infusions (pDLI)

G. Mufti, D. Mclornan, H. de Lavallade, 2019, Bone Marrow Transplantation.

Bacterial mutagenicity screening in the pharmaceutical industry.

R. Snyder, B. Mahadevan, S. Sawant, 2013, Mutation research.

Reduced-intensity allogeneic hematopoietic stem cell transplantation with alemtuzumab conditioning regimens: survival does not plateau until after day 200.

G. Mufti, A. Ho, S. Devereux, 2003, Blood.

Systematic screening and focused evaluation for venous occlusive disease/sinusoidal obstructive syndrome (VOD/SOS) following allogeneic stem cell transplant is associated with earlier diagnosis and prompt institution of defibrotide treatment

F. Dazzi, Prue J. Hardefeldt, A. Pagliuca, 2022, Frontiers in Transplantation.

Long-term outcomes of alemtuzumab-based reduced-intensity conditioned hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myelogenous leukemia secondary to myelodysplastic syndrome.

G. Mufti, R. Marcus, R. Ireland, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Benchmarking of survival outcomes following Haematopoietic Stem Cell Transplantation (HSCT): an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE)

M. Labopin, M. Mohty, J. Snowden, 2023, Bone Marrow Transplantation.

Survivorship care for allogeneic transplant patients in the UK NHS: changes centre practice, impact of health service policy and JACIE accreditation over 5 years

J. Byrne, R. Malladi, J. Snowden, 2020, Bone Marrow Transplantation.

In silico methods combined with expert knowledge rule out mutagenic potential of pharmaceutical impurities: an industry survey.

Nigel Greene, Susanne Glowienke, James S Harvey, 2012, Regulatory toxicology and pharmacology : RTP.

Living with and beyond a haematological malignancy

J. Murray, M. Kenyon, 2017 .

Evaluation of the in vivo mutagenicity of isopropyl methanesulfonate in acute and 28‐day studies

Krista L Dobo, M. Kenyon, J. Ackerman, 2015, Environmental and molecular mutagenesis.

Nursing Research and Audit in the Transplant Setting -- The European Blood and Marrow Transplantation Textbook for Nurses: Under the Auspices of EBMT

A. Babić, M. Kenyon, 2018 .

Strategies for Assessing Acceptable Intakes for Novel N-Nitrosamines Derived from Active Pharmaceutical Ingredients.

Krista L Dobo, A. Kalgutkar, M. Kenyon, 2022, Journal of medicinal chemistry.

Permitted daily exposure limits for noteworthy N‐nitrosamines

Krista L Dobo, Ryan P Wheeldon, G. Johnson, 2021, Environmental and molecular mutagenesis.

The EBMT Immune Effector Cell Nursing Guidelines on CAR-T Therapy: A Framework for Patient Care and Managing Common Toxicities

S. Montoto, M. Mohty, C. Chabannon, 2022, Clinical Hematology International.

A pharma-wide approach to address the genotoxicity prediction of primary aromatic amines

Mick D. Fellows, Robert A. Jolly, Alexander Amberg, 2018, Computational Toxicology.

An evaluation of the sensitivity of the Ames assay to discern low-level mutagenic impurities.

Warren W Ku, Krista L Dobo, M. Kenyon, 2007, Regulatory toxicology and pharmacology : RTP.

In silico toxicology protocols.

Tudor I. Oprea, Naomi L Kruhlak, Lidiya Stavitskaya, 2018, Regulatory toxicology and pharmacology : RTP.

Life coaching following haematopoietic stem cell transplantation: a mixed-method investigation of feasibility and acceptability.

G. Mufti, E. Ream, Z. Lim, 2015, European journal of cancer care.

Resolution of contradiction between in silico predictions and Ames test results for four pharmaceutically relevant impurities

R. W. Dugger, M. Kenyon, J. Cheung, 2017, Regulatory toxicology and pharmacology : RTP.

2‐Hydroxypyridine‐N‐oxide (HOPO): Equivocal in the ames assay

M. Kenyon, J. Cheung, K. Dobo, 2018, Environmental and molecular mutagenesis.

Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: is aromatic N-oxide a structural alert for predicting DNA-reactive mutagenicity?*

Naomi L Kruhlak, Lidiya Stavitskaya, Alexander Amberg, 2018, Mutagenesis.

Potential impurities in drug substances: Compound‐specific toxicology limits for 20 synthetic reagents and by‐products, and a class‐specific toxicology limit for alkyl bromides

S. Galloway, V. Thybaud, R. Jolly, 2018, Regulatory toxicology and pharmacology : RTP.

Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: A case study using aromatic amine mutagenicity.

Lidiya Stavitskaya, Alexander Amberg, Masamitsu Honma, 2016, Regulatory toxicology and pharmacology : RTP.

The European Blood and Marrow Transplantation Textbook for Nurses: Under the Auspices of EBMT

A. Babić, M. Kenyon, 2018 .

Acceptable Intakes (AIs) for 11 Small molecule N-nitrosamines (NAs).

R. Weaver, A. Czich, D. Snodin, 2023, Regulatory toxicology and pharmacology : RTP.

Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT)

F. Baron, I. Yakoub-Agha, D. Blaise, 2023, Bone Marrow Transplantation.

Provision of long-term monitoring and late effects services following adult allogeneic haematopoietic stem cell transplant: a survey of UK NHS-based programmes

J. Snowden, D. Greenfield, B. Shaw, 2017, Bone Marrow Transplantation.

Establishing best practise in the application of expert review of mutagenicity under ICH M7.

Lidiya Stavitskaya, Alexander Amberg, Steve Gutsell, 2015, Regulatory toxicology and pharmacology : RTP.

Matched Pair Analysis of Intravenous vs Oral Busulphan as Part of Fludarabine-Busulphan-Campath (Alemtuzumab) Reduced Intensity Conditioning (RIC) Haematopoietic Stem Cell Transplantation (HSCT).

G. Mufti, Z. Lim, L. Pearce, 2005 .

Principles and procedures for handling out-of-domain and indeterminate results as part of ICH M7 recommended (Q)SAR analyses

Lidiya Stavitskaya, Raymond Kemper, Glenn J. Myatt, 2018, Regulatory toxicology and pharmacology : RTP.

Anti‐type M phospholipase A2 receptor antibody‐positive membranous nephropathy as a part of multi‐system autoimmune syndrome post‐allogeneic stem cell transplantation

G. Mufti, D. Mclornan, H. de Lavallade, 2018, Internal medicine journal.

Specialized Pediatric Palliative Care Services in Pediatric Hematopoietic Stem Cell Transplant Centers

P. Bader, A. Kozijn, D. Hutt, 2021, Children.

Early and Acute Complications and the Principles of HSCT Nursing Care -- The European Blood and Marrow Transplantation Textbook for Nurses: Under the Auspices of EBMT

A. Babić, M. Kenyon, 2018 .

Safe transfer of pediatric patients from hematopoietic stem cell transplant unit into the pediatric intensive care unit: views of nurses and physicians

P. Veys, J. Wachowiak, P. Bader, 2022, Bone Marrow Transplantation.

Myeloablative dose of busulfan and fludarabine combined with in vivo T-cell depletion is a safe and effective conditioning for acute myeloid leukaemia and myelodysplastic syndrome patients.

F. Dazzi, A. Pagliuca, M. Kenyon, 2023, Transplantation and cellular therapy.

Practice harmonization workshops of EBMT: an expert-based approach to generate practical and contemporary guidelines within the arena of hematopoietic cell transplantation and cellular therapy

I. Yakoub-Agha, J. Snowden, D. Mclornan, 2023, Bone Marrow Transplantation.

The in vivo Pig-a assay: A report of the International Workshop On Genotoxicity Testing (IWGT) Workgroup.

K. Witt, S. Dertinger, J. Tanir, 2015, Mutation research. Genetic toxicology and environmental mutagenesis.

Nonmyeloablative peripheral blood haploidentical stem cell transplantation for refractory severe aplastic anemia.

G. Mufti, D. Mclornan, H. de Lavallade, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy.

J. Salisbury, G. Mufti, D. Creamer, 2007, Archives of dermatology.

Calculating Qualified Non-Mutagenic Impurity Levels: Harmonization of Approaches.

J. Bercu, M. Kenyon, M. Powley, 2021, Regulatory toxicology and pharmacology : RTP.

Evaluation of the in vivo mutagenicity of isopropyl methanesulfonate in acute and 28‐day studies

Krista L Dobo, M. Kenyon, J. Ackerman, 2015, Environmental and molecular mutagenesis.

Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: A case study using aromatic amine mutagenicity.

Donald P. Quigley, G. Myatt, K. Cross, 2016, Regulatory toxicology and pharmacology : RTP.